Indiana CNG Stations Land New Owner

Posted: Updated:
(file photo) (file photo)
NEW YORK -

Five compressed natural gas fueling stations throughout Indiana are now under new ownership. New York-based American Natural Gas LLC has acquired Baltimore-based Constellation CNG LLC, which owned fueling stations in Indiana and Ohio.

The fueling stations are located in Fort Wayne, Greensburg, Indianapolis, Lafayette and Seymour. Constellation also owned stations in Dayton and Findlay, Ohio. Financial terms of the acquisition were not disclosed.

"Our customers’ needs are driving our expansion," said Drew West, chief executive officer of ANG. "With a national footprint, ANG is situated better than ever to support fleets across the country in broader, more extensive adoptions of CNG. These strategic purchases align with our mission to expand our CNG network, extend the reach of alternative fuels, and continue to meet the needs of this growing industry."

Constellation CNG originally took ownership of the Indiana and Ohio stations in January 2015.

In a separate transaction, ANG also acquired Questar Fueling Co., which owned 11 CNG fueling stations in Arizona, Kansas, Texas, Utah, California and Colorado. ANG's parent company, HC2 Holdings Inc. (NYSE: HCHC), did not state whether any jobs would be affected by the acquisitions.

  • Perspectives

    • How Managers Can Keep Millennials Happy

      There are more than 56 million Millennials either actively participating in the workforce, or searching for a job. With a number like this, it’s no surprise that Millennials have taken the workplace by storm. But what is surprising is how different this generation is from their predecessors. They rely heavily on technology and prefer to communicate via text or email rather than a traditional phone call. Managing millennial employees can be a challenge — how can executives...

    More

Events



  • Most Popular Stories

    • $25M Behavioral Hospital Coming to Central Indiana

      Danville-based Hendricks Regional Health is partnering with US HealthVest to develop a stand-alone behavioral center on the Hendricks campus in Plainfield. Known as the Indianapolis Behavioral Hospital, the facility will provide specialized inpatient and outpatient mental health care to patients of all ages.

    • How Managers Can Keep Millennials Happy

      There are more than 56 million Millennials either actively participating in the workforce, or searching for a job. With a number like this, it’s no surprise that Millennials have taken the workplace by storm. But what is surprising is how different this generation is from their predecessors. They rely heavily on technology and prefer to communicate via text or email rather than a traditional phone call. Managing millennial employees can be a challenge — how can executives...

    • Christel DeHaan to Retire as Christel House CEO

      One of the biggest names in philanthropy in Indiana is announcing her retirement. Christel House International Chief Executive Officer Christel DeHaan will remain board chair, but leave as CEO of the nonprofit she founded 20 years ago. The organization has named former Indianapolis Mayor Bart Peterson to be her successor. CHI's mission is to lift children out of poverty, and it has established learning centers at home in Indianapolis and abroad in Mexico, India, South Africa and...

    • Sturges, CBRE Splitting Up

      A long-time commercial real estate firm in Fort Wayne is going independent. CBRE | Sturges, which became affiliated with the global brand more than 20 years ago, will become Sturges Property Group at the end of this month. The firm was founded in 1975 and bills itself as largest full-service commercial and industrial real estate firm in the region. The shift, Sturges says, will...

    • Endocyte, Novartis Ink $2.1B Merger Agreement

      West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) has announced a merger agreement with a global pharmaceutical giant. The deal with Switzerland-based Novartis AG is valued at $2.1 billion and still requires shareholder approval. Until regulatory and other approvals are met, Endocyte will remain independent. The proposed merger of Endocyte into Novartis is slated to be complete in the first half of next year. Endocyte develops targeted cancer therapies and earlier this...